Evidence map›Paper›PMID 34102297›Full record

ArticleInternational journal of radiation oncology, biology, physics2021

Quality of Life Is Independently Associated With Neurocognitive Function in Patients With Brain Tumors: Analysis of a Prospective Clinical Trial.

Mia Salans, Michelle D Tibbs, Minh-Phuong Huynh-Le, Anthony Yip, Kathryn Tringale, Roshan Karunamuni, Ronghui Xu, Anny Reyes, Anna Christina Macari, Tonya Pan-Weisz and 2 more

Open access · greenAbstract read
In one paragraph

Article in International journal of radiation oncology, biology, physics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Mia SalansDepartment of Radiation Medicine and Applied Sciences, University of California San Diego, San Diego, California.
Michelle D TibbsDepartment of Radiation Medicine and Applied Sciences, University of California San Diego, San Diego, California.
Minh-Phuong Huynh-LeDepartment of Radiation Medicine and Applied Sciences, University of California San Diego, San Diego, California.
Anthony YipDepartment of Radiation Medicine and Applied Sciences, University of California San Diego, San Diego, California.
Kathryn TringaleDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Roshan KarunamuniDepartment of Radiation Medicine and Applied Sciences, University of California San Diego, San Diego, California.
Ronghui XuDepartment of Mathematics, University of California San Diego, San Diego, California.
Anny ReyesDepartment of Psychiatry, University of California San Diego, San Diego, California.
Anna Christina MacariDepartment of Psychiatry, University of California San Diego, San Diego, California.
Tonya Pan-WeiszDepartment of Psychiatry, University of California San Diego, San Diego, California.
Carrie R McDonaldDepartment of Radiation Medicine and Applied Sciences, University of California San Diego, San Diego, California; Department of Psychiatry, University of California San Diego, San Diego, California.
Jona A Hattangadi-GluthDepartment of Radiation Medicine and Applied Sciences, University of California San Diego, San Diego, California. Electronic address: jhattangadi@health.ucsd.edu.
University of California San Diego · USMemorial Sloan Kettering Cancer Center · USUC San Diego Health System · USUniversity of San Diego · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
UC San Diego Clinical and Translational Research InstituteUL1TR001442 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S, HOGARTH, MICHAEL · 2015 to 2024
$88.3M
San Diego Clinical and Translational Research InstituteUL1TR000100 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S · 2012 to 2015
$19.7M
UC San Diego Clinical and Translational Research InstituteKL2TR001444 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DEPP, COLIN A. · 2015 to 2024
$15.4M
UC San Diego Clinical and Translational Research InstituteTL1TR001443 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DEPP, COLIN A. · 2015 to 2019
$3.4M
Image-Guided Cognitive-Sparing Radiosurgery for Brain Metastases: Avoidance of Eloquent White Matter and Hippocampal RegionsR01CA238783 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HATTANGADI-GLUTH, JONA A · 2019 to 2021
$737k
Explaining cognitive heterogeneity in temporal lobe epilepsy (TLE): Identifying unique imaging features, health-related risk factors and protective factors in TLE subtypesF31NS111883 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI REYES, ANNY · 2019 to 2021
$89k
HSRD VA TPR 15-229NCATS NIH HHS KL2 TR001444NCATS NIH HHS TL1 TR001443NCATS NIH HHS UL1 TR000100NCATS NIH HHS UL1 TR001442NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA238783NINDS NIH HHS F31 NS111883
6 · The paper itself

Abstract

purposeWe conducted the first prospective longitudinal study examining the independent association between patient-reported health-related quality of life (hrQoL) (physical, social/family, emotional, functional, and brain cancer-specific) and neurocognitive function (NCF), while controlling for mood symptoms in patients with primary brain tumors. METHODS AND MATERIALS: Patients with primary brain tumors (n = 59) receiving brain radiation therapy underwent hrQOL (Functional Assessment of Cancer Therapy-Brain), mood (Beck Depression and Anxiety Inventories), and neurocognitive evaluation at baseline and 3, 6, and 12 months postradiation therapy in a prospective clinical trial. Neurocognitive assessments measured attention/processing speed, memory, and executive function, including the Delis-Kaplan Executive Function System Verbal Fluency, Hopkins Verbal Learning Test Revised (HVLT-R), and Brief Visuospatial Memory Test. Subjects underwent neurocognitive, mood, and hrQoL assessments in the same testing session. Multivariable linear mixed-effects models assessed associations between hrQOL and NCF over time, controlling for patient, tumor, and treatment characteristics as well as timepoint-specific patient-reported mood (ie, anxiety and depression symptoms). P values were adjusted for multiple comparisons.

resultsHigher physical hrQoL was associated with better verbal memory (HVLT-R Total Recall, P = .047), and higher functional hrQoL was associated with better executive function (Delis-Kaplan Executive Function System Verbal Fluency Switching Total, P = .009) and verbal memory (HVLT-R Delayed Recall, P = .006). Higher brain tumor-specific hrQoL was associated with better verbal and nonverbal memory (HVLT-R Total, P = .004 and Delayed Recall, P = .030; Brief Visuospatial Memory Test Total, P = .049 and Delayed Recall, P = .049). There was no association between social/family or emotional hrQoL and NCF after controlling for mood.

conclusionsHigher physical, functional, and brain tumor-specific hrQoL were associated with better executive function and memory among patients with primary brain tumors. Physical and functional impairments are correlated with cognitive performance. Interventions to maximize quality of life after treatment may influence neurocognition and vice versa.

Indexed as

Brain NeoplasmsQuality of LifeHumansLongitudinal StudiesNeuropsychological TestsProspective Studies

Identifiers

PMID34102297
PMCPMC8463493
OpenAlexW3168522637

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.